For research use only
| Cat No. | ABC-TC1292 |
| Product Type | Human Melanoma Cell Lines |
| Cell Type | Epithelial |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Product Code | WM-266-4; WM 266-4; WM-2664; WM2664; WM 2664; WM266; WM-266-mel; WM266mel; WC00097 |
Human WM-266-4 melanoma cells with BRAF V600D mutation and PTEN deletion, used for metastatic melanoma and tumorigenesis research.
| Product Code | WM-266-4; WM 266-4; WM-2664; WM2664; WM 2664; WM266; WM-266-mel; WM266mel; WC00097 |
| Species | Human |
| Cat.No | ABC-TC1292 |
| Product Category | Tumor Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Epithelial |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Human Melanoma Cell Lines |
The WM-266-4 cell line is crucial in immuno-oncology for uncovering signaling pathways involved in tumor immune escape. Researchers use it to study IFN-γ stimulation and its impact on immune checkpoint inhibitor expression in melanoma cells. Additionally, WM-266-4 helps identify and investigate novel therapeutic targets for melanoma, shedding light on mechanisms that may induce antiproliferative and proapoptotic effects. This cell line is instrumental in advancing pharmacological treatments for melanoma, contributing to the development of new and more effective therapies.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
WM-266-4 cells are a metastatic human melanoma cell line that derived from a metastatic site of a malignant melanoma.
The culture medium recommended for WM-266-4 cells is composed of High Glucose 1640 supplemented with appropriate additives to support optimal cell growth and maintenance, adding 10% FBS.
The applications include cellular assay, genetic studies, xenograft production, drug testing
